Maravai LifeSciences Holdings, Inc. Deferred Income Tax Expense (Benefit)
Maravai LifeSciences Holdings, Inc. (MRVI) reported Deferred Income Tax Expense (Benefit) of -$20.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-02-26
- Maravai LifeSciences Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2024-12-31 was $11.00K, a 100.00% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2024-09-30 was $0.00.
- Maravai LifeSciences Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2024-06-30 was $0.00.
- Maravai LifeSciences Holdings, Inc. deferred income tax expense (benefit) for the quarter ending 2024-03-31 was $0.00.
- Maravai LifeSciences Holdings, Inc. deferred income tax expense (benefit) for fiscal 2025 was -$20.00K, a 281.82% decline from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. deferred income tax expense (benefit) for fiscal 2024 was $11.00K, a 100.00% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. deferred income tax expense (benefit) for fiscal 2023 was $754.94M, a 1683.97% increase from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. deferred income tax expense (benefit) for fiscal 2022 was $42.32M, a 9.78% decline from fiscal 2021.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$20.00K 10-K · filed 2026-02-26 | |||
| 2024-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $11.00K derived: sum of 2 quarters · filed 2026-02-26 | $11.00K derived: sum of 3 quarters · filed 2026-02-26 | $11.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $764.75M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $764.75M derived: sum of 3 quarters · filed 2026-02-26 | $759.22M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $764.75M derived: sum of 2 quarters · filed 2026-02-26 | $759.22M derived: sum of 3 quarters · filed 2026-02-26 | $756.46M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $764.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $759.22M derived: sum of 2 quarters · filed 2026-02-26 | $756.46M derived: sum of 3 quarters · filed 2026-02-26 | $754.94M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$5.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$8.29M derived: sum of 2 quarters · filed 2024-11-12 | -$9.81M 10-Q · filed 2024-11-12 | -$2.80M derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-06-30 | -$2.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$4.28M 10-Q · filed 2024-08-08 | $2.73M derived: sum of 3 quarters · filed 2025-03-18 | $11.97M derived: sum of 4 quarters · filed 2025-03-18 |
| 2023-03-31 | -$1.52M 10-Q · filed 2024-05-09 | $5.49M derived: sum of 2 quarters · filed 2025-03-18 | $14.72M derived: sum of 3 quarters · filed 2025-03-18 | $27.58M derived: sum of 4 quarters · filed 2025-03-18 |
| 2022-12-31 | $7.01M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $16.25M derived: sum of 2 quarters · filed 2025-03-18 | $29.10M derived: sum of 3 quarters · filed 2025-03-18 | $42.32M 10-K · filed 2025-03-18 |
| 2022-09-30 | $9.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $22.09M derived: sum of 2 quarters · filed 2023-11-08 | $35.31M 10-Q · filed 2023-11-08 | $52.77M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $12.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $26.07M 10-Q · filed 2023-08-08 | $43.54M derived: sum of 3 quarters · filed 2024-02-29 | $54.77M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $13.22M 10-Q · filed 2023-05-09 | $30.68M derived: sum of 2 quarters · filed 2024-02-29 | $41.91M derived: sum of 3 quarters · filed 2024-02-29 | $48.36M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $17.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $28.69M derived: sum of 2 quarters · filed 2024-02-29 | $35.14M derived: sum of 3 quarters · filed 2024-02-29 | $46.90M 10-K · filed 2024-02-29 |
| 2021-09-30 | $11.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $17.68M derived: sum of 2 quarters · filed 2022-11-04 | $29.44M 10-Q · filed 2022-11-04 | $25.25M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $6.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $18.21M 10-Q · filed 2022-08-05 | $14.02M derived: sum of 3 quarters · filed 2023-02-28 | $14.02M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $11.76M 10-Q · filed 2022-05-06 | $7.57M derived: sum of 2 quarters · filed 2023-02-28 | $7.57M derived: sum of 3 quarters · filed 2023-02-28 | $7.57M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$4.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$4.19M derived: sum of 2 quarters · filed 2023-02-28 | -$4.19M derived: sum of 3 quarters · filed 2023-02-28 | -$5.46M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$1.00K derived: sum of 2 quarters · filed 2021-11-15 | -$1.27M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$1.27M 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | -$1.27M 10-Q · filed 2021-05-12 | |||
| 2019-12-31 | -$1.16M 10-K · filed 2022-03-01 |